[S-08] Symposium 08 RBD as a harbinger of synucleinopathy: update

[S-08-1] Melatonin Therapy in iRBD

^○Dieter Kunz (Department of Physiology, Charite - Universitymedicine Berlin, Germany)

Dieter Kunz graduated in 1989, performed residencies in neurology / psychiatry, and was appointed supervising physician in 1996 at the Freie Universität Berlin. After three years at Lübeck University, he was appointed head of the Psychiatric University Clinic Charité in St. Hedwig Hospital in 2002. He transformed this former community-based clinic into an efficient 120-inpatient university clinic, established teaching, research, and clinical practice on academic level.

Dr. Kunz’s main interest, however, is neurological/psychiatric sleepresearch. In January 2008, he was appointed head of the newly founded Clinic of Sleep- & Chronomedicine in St. Hedwig Hospital. He also is director of the group Sleep Research & Clinical Chronobiology at Charité - Universitätsmedizin Berlin. Main areas of research are circadian aspects of human sleep including the nonvisual effects of light and the pharmacological effects of melatonin (hormone of darkness) on human physiology and behavior.

Dr. Kunz is frequent grant reviewer such as for National Science Foundation (NSF), the European Commission (EU), European Space Agency (ESA), and Wellcome Trust. As principal investigator he successfully applied for public European and German grants and industry grants including pharmacological phase-2 and -3 studies. He has published over 80 original papers in peer reviewed journals.